Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

• Status: Completed
• Trial end date: 2010-10-01

Summary

We propose to use an inhaled allergen challenge model to explore the individual contributions of the components of a novel long-acting beta agonist (LABA)/ inhaled corticosteroid (ICS) combination product on protection from allergic triggers in asthma.

• Phase: Phase 2

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone; Xhance